Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: A placebo-controlled, double-blind study

Journal of Dermatology

Volumn 25, Issue 5, 1998, Pages 309-313

  Syed, Tanweer A ^a,e   Goswami, Jagdish ^b   Ahmadpour, Oliver Abbas ^c   Ahmad, Seyed Ali ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Urmi Clinic   (India)

^c UMEÅ UNIVERSITY   (Sweden)

^d Windsor High School   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Henderson Patterson bodies; Imiquimod; Molluscum contagiosum

Indexed keywords

IMIQUIMOD;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLLUSCUM CONTAGIOSUM; SKIN BIOPSY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031806772     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1998.tb02403.x     Document Type: Article

References (14)

1. Yamashita H, Uemura T, Kawashima M: Molecular epidemiologic analysis of Japanese patients with molluscum contagiosum, Int J Dermatol, 35: 99-105, 1996.
2. Nunez A, Funes JM, Agromayor M, et al: Detection and typing of molluscum contagiosum virus in skin lesions by using a simple lysis method and polymerase chain reaction, J Med Virol, 50: 342-349, 1996.
3. Takematsu H, Tagami H: Proinflammatory properties of molluscum bodies, Arch Dermatol Res, 287: 102-106, 1994.
4. Friedman M, Gal D: Keloid scars as a result of carbon dioxide laser for molluscum contagiosum, Obstet Gynecol, 70: 394-396, 1987.
5. Syed TA, Lundin S, Ahmad M: Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males, Dermatology, 189: 65-68, 1994.
6. Deleixhe M, Piérard-Franchimont C, Piérard GE: Podophyllotoxin in the treatment of mollnscum contagiosum, J Dermatol Treat, 2: 99-101, 1991.
7. Witt PL, Ritch PS, Reding D, et al: Phase I trial of an oral immunomodulator and interferon inducer in cancer patients, Cancer Res, 53: 5176-5180, 1993.
8. Baker GE, Tyring SK: Therapeutic approaches to papillomavirus infections, Dermatol Clin, 15: 331-340, 1997.
9. Lacey GJN, Fairley I: Medical therapy of genital human papilloma virus-related disease, Int J of STD & AIDS, 6: 399-407, 1995.
10. Syed TA, Ahmadpour OA, Ahmad SA, Ahmad SH: Management of genital warts in women with an analog of imiquimod 2% in cream: A randomized, double-blind, placebo-controlled study, J Dermatol. (in press)
11. Forghani B, Oshiro LS, Chan CS, et al: Direct detection of molluscum contagiosum virus in clinical specimens by in situ hybridization using biotinylated probe, Mol Cell Probes, 6: 67-77, 1992.
12. Imbertson LM, Weeks C, Adams N, et al: Induction of antiviral activity and cytokines by oral imiquimod in healthy volunteers, J Interferon Res, 12: s127, 1992.
13. Tomai MA, Birmachu W, Case MT et al: Imiquimod: In vivo and in vitro characteristics and Toxicology, in Aly R, Beutner KR, Maibach H (eds): Cutaneous Infection and Therapy, New York, Marcel Dekker Inc, New York, 1997, pp 405-415.
14. Megyeri K, Au W-C, Rosztoczy I, et al: Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by sendai virus utilize similar signal transduction pathways, Mol Cell Biol, 15: 2207-2218, 1995.